Hrt Financial LP Stealth Bio Therapeutics Corp Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.18 - $0.71 $6,541 - $25,802	36,342 New	36,342 $9,000
Q4 2021 Feb 14, 2022	SELL	$0.76 - $1.48 $15,074 - $29,355	-19,835 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.17 - $1.58 $2,770 - $3,741	2,368 Added 13.56%	19,835 $26,000
Q2 2021 Aug 16, 2021	SELL	$1.07 - $1.77 $535 - $885	-500 Reduced 2.78%	17,467 $27,000
Q1 2021 May 17, 2021	BUY	$1.38 - $2.42 $24,794 - $43,480	17,967 New	17,967 $28,000
Q4 2020 Feb 16, 2021	SELL	$1.27 - $1.62 $21,706 - $27,689	-17,092 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.32 - $2.23 $4,410 - $7,450	3,341 Added 24.3%	17,092 $0
Q2 2020 Aug 14, 2020	BUY	$1.23 - $2.22 $16,913 - $30,527	13,751 New	13,751 $25,000

2.94K

Ticker MITO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,548,600
Description
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duche...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.